JY
PRNB

Jeff Yass’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Jeff Yass’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-9,653
Closed -$577K – 11457
2020
Q2 		$577K Sell
9,653
-487
-5% -$30.1K ﹤0.01% 7074
2020
Q1 		$602K Buy
+10,140
New +$591K ﹤0.01% 6525
2019
Q4 		– Sell
-21,437
Closed -$800K – 11097
2019
Q3 		$605K Buy
21,437
+4,351
+25% +$160K ﹤0.01% 6852
2019
Q2 		$567K Buy
+17,086
New +$533K ﹤0.01% 7028

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Jeff Yass's PRNB Position: Q3 2020 in Review

Jeff Yass sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 9,653 shares — an estimated $577K sold.

Jeff Yass first reported a position in PRNB in Q2 2019 and held it in 4 quarters. The position peaked at $605K in Q3 2019. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • Jeff Yass reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Jeff Yass sold 9,653 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $577K.
  • Jeff Yass first reported a position in Principia Biopharma Inc. Common Stock in Q2 2019 and held it in 4 quarters.
  • Jeff Yass's Principia Biopharma Inc. Common Stock position peaked at $605K in Q3 2019.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Susquehanna International Group's 13F filing for Q3 2020, filed 16 Nov 2020.